TAKEDA PHARMACEUTICAL CO LTD - 21 Jun 2021 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: 10%+ Owner
Signature: /s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Issuer symbol: PHAT
Transactions as of: 21 Jun 2021
Net transactions value: -$331,671
Form type: 4
Filing time: 23 Jun 2021, 06:15:35 UTC
Previous filing: 21 Jun 2021
Next filing: 25 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Sale	$328,171	-9,294	-1%	$35.31	917,889	21 Jun 2021	Direct	F1, F2
transaction	PHAT	Common Stock	Sale	$3,500	-100	-0.01%	$35.00	917,789	22 Jun 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.
F2	Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.87. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.